Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Corporate Presentation services provided by Evonik

Evonik
Corporate Presentation
Full Screen View

PDF Upload Apr, 2024

European Food Safety Authority confirms safety of silica

26 Oct 2024

// PRESS RELEASE

Evonik plots 260 layoffs as it winds down some production ops

14 Oct 2024

// FIERCE PHARMA

Evonik to Restructure Keto and Pharma Amino Acid Business

11 Oct 2024

// PRESS RELEASE

DATA COMPILATION
#PharmaFlow

Evonik

Contact Supplier

IPPE

Attending

Book a meeting

envelop Contact Supplier

Latest Content by PharmaCompass

https://www.youtube.com/embed/NU_W8oLFfZE

Xls

CATEGORY PAGE

Evonik

VISIT THE VIRTUAL BOOTH, Contact Details

VISIT THE VIRTUAL BOOTH
Review portfolio & marketing content
CONTACT DETAILS
Google Map, LinkedIn, Emails...

EVENTS

Webinars & Exhibitions

Webinars & Exhibitions

PRESENTATION(s)

Product List 2024, Corporate Presentation, GMP Certificate 2024, Rexiva®, Lipid-based Delivery of Nucleic Acids, PhytoSquene®, Nutraceutical Solutions, Evonik Strengthens its Animal Nutrition Business, New U.S Facility for Pharmaceutical Lipids, Production Capacity for DL-Methionine in Singapore, Evonik invests $220M with US Govt. for lipid production facility, Specialty Additives Division Spotlight, cQrex™ Cell Culture Solutions, Complex Parenterals, Exclusive Synthesis, Oral Drug Delivery Solutions, Resomer® , Nutrition & Care Divison Spotlight, Smart Materials Division Spotlight, Eudragit®, PhytoChol®, Custom Lipids, Evonik Birmingham Laboratories, High-quality Generic APIs, Intermediates & Amino Acids, Your Enabling Partner for Oral Drug Delivery Solutions

Product List 2024
Corporate Presentation
GMP Certificate 2024
Rexiva®
Lipid-based Delivery of Nucleic Acids
PhytoSquene®
Nutraceutical Solutions
Evonik Strengthens its Animal Nutrition Business
New U.S Facility for Pharmaceutical Lipids
Production Capacity for DL-Methionine in Singapore
Evonik invests $220M with US Govt. for lipid production facility
Specialty Additives Division Spotlight
cQrex™ Cell Culture Solutions
Complex Parenterals
Exclusive Synthesis
Oral Drug Delivery Solutions
Resomer®
Nutrition & Care Divison Spotlight
Smart Materials Division Spotlight
Eudragit®
PhytoChol®
Custom Lipids
Evonik Birmingham Laboratories
High-quality Generic APIs, Intermediates & Amino Acids
Your Enabling Partner for Oral Drug Delivery Solutions

VIDEO(s)

AMINOSys®, Applied Technology Center, Catalysts - Adsorbent Solutions, Custom Catalysts, Interface & Performance Laboratory, TEGO® Foamex 8880, Lipid Innovation Center, cQrex® AC, Discover Our New Oral Drug Delivery Lab in Istanbul, CDMO for Advanced Drug Delivery, EUDRATEC® SoluFlow, Drawing Drug Delivery: Liposomes, Coatino®, Evonik Delivers First Lipids from German Facility to BioNTech, Hydrogen Peroxide, Polyamide 12, SEPURAN® Green, Specialty Additives

AMINOSys®
Applied Technology Center
Catalysts - Adsorbent Solutions
Custom Catalysts
Interface & Performance Laboratory
TEGO® Foamex 8880
Lipid Innovation Center
cQrex® AC
Discover Our New Oral Drug Delivery Lab in Istanbul
CDMO for Advanced Drug Delivery
EUDRATEC® SoluFlow
Drawing Drug Delivery: Liposomes
Coatino®
Evonik Delivers First Lipids from German Facility to BioNTech
Hydrogen Peroxide
Polyamide 12
SEPURAN® Green
Specialty Additives

DIGITAL CONTENT

43 CORPORATE CONTENT #SupplierSpotlight, 3 DATA COMPILATION #PharmaFlow, 242 NEWS #PharmaBuzz

43 CORPORATE CONTENT #SupplierSpotlight
3 DATA COMPILATION #PharmaFlow
242 NEWS #PharmaBuzz

ACTIVE PHARMA INGREDIENTS

40 All APIs, 14 USDMF, 23 CEP/COS, 27 JDMF, 7 KDMF, 22 NDC API, 2 VMF, 4 Listed APIs

40 All APIs
14 USDMF
23 CEP/COS
27 JDMF
7 KDMF
22 NDC API
2 VMF
4 Listed APIs

DEVELOPMENTS

7 Drugs in Development

7 Drugs in Development

SERVICES

API Manufacturing, Drug Product Manufacturing, API & Drug Product Development

API Manufacturing
Drug Product Manufacturing
API & Drug Product Development
- 3 API Development
- 5 Formulation Development

KEY SERVICES

Oral Technologies, CMO for Controlled Substances, Microbial Fermentation, API Contract Manufacturing, Chiral Synthesis, Drug Delivery Technology, Hot Melt Extrusion, Coating Technology, CDMO for HPAPIs

Oral Technologies
CMO for Controlled Substances
Microbial Fermentation
API Contract Manufacturing
Chiral Synthesis
Drug Delivery Technology
Hot Melt Extrusion
Coating Technology
CDMO for HPAPIs

EXCIPIENTS

27 All Excipients, 27 USDMF, 1 NDC API, 2 VMF, 22 Listed Products

27 All Excipients
27 USDMF
1 NDC API
2 VMF
22 Listed Products

EXCIPIENTS BY INGREDIENTS

L Lysine HCl Excipient, Glycine Excipient, L-Aspartic Acid, Ammonia Methacrylate Copolymer Type A, L-Valine Excipient, L Serine Excipient, L-Proline, DL-Glutamic Acid, Ammonio Methacrylate Copolymer Type B, L-Lysine Acetate, L Threonine Excipient, Methacrylic Acid Copolymer Type B, METHACRYLIC ACID COPOLYMER TYPE A , L-Phenylalanine, L Tryptophan Excipient, Methacrylic Acid - Ethyl Acrylate Copolymer, PLASACRYL HTP20, L-Leucine, DL-Methionine Excipient, L-Alanine, Amino Methacrylate Copolymer, PLASACRYL T20

L Lysine HCl Excipient
Glycine Excipient
L-Aspartic Acid
Ammonia Methacrylate Copolymer Type A
L-Valine Excipient
L Serine Excipient
L-Proline
DL-Glutamic Acid
Ammonio Methacrylate Copolymer Type B
L-Lysine Acetate
L Threonine Excipient
Methacrylic Acid Copolymer Type B
METHACRYLIC ACID COPOLYMER TYPE A
L-Phenylalanine
L Tryptophan Excipient
Methacrylic Acid - Ethyl Acrylate Copolymer
PLASACRYL HTP20
L-Leucine
DL-Methionine Excipient
L-Alanine
Amino Methacrylate Copolymer
PLASACRYL T20

EXCIPIENTS BY APPLICATIONS

Topical, Controlled & Modified Release, Solubilizers, Film Formers & Plasticizers, Lubricants & Glidants, Disintegrants & Superdisintegrants, Taste Masking, Thickeners and Stabilizers, Coating Systems & Additives

Topical
Controlled & Modified Release
Solubilizers
Film Formers & Plasticizers
Lubricants & Glidants
Disintegrants & Superdisintegrants
Taste Masking
Thickeners and Stabilizers
Coating Systems & Additives

INSPECTIONS & REGISTRATIONS

49 FDA, 28 EDQM, 2 GDUFA

49 FDA
28 EDQM
2 GDUFA

PC100329

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?